Cargando…
The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice
PURPOSE: Malignant pleural mesothelioma (MPM) is a highly lethal neoplasm. S-1 has been developed as a novel oral antineoplastic agent based on the modulation of 5-fluorouracil (5-FU) bioactivity. This study was conducted to investigate the preclinical therapeutic effect of S-1 on MPM. METHODS: We u...
Autores principales: | Van, Trung The, Hanibuchi, Masaki, Kakiuchi, Soji, Sato, Seidai, Kuramoto, Takuya, Goto, Hisatsugu, Mitsuhashi, Atsushi, Nishioka, Yasuhiko, Akiyama, Shin-ichi, Sone, Saburo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143341/ https://www.ncbi.nlm.nih.gov/pubmed/21079960 http://dx.doi.org/10.1007/s00280-010-1503-x |
Ejemplares similares
-
Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target
por: Huang, Jun, et al.
Publicado: (2013) -
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
por: Mitsuhashi, Atsushi, et al.
Publicado: (2015) -
Thymidine catabolism promotes NADPH oxidase-derived reactive oxygen species (ROS) signalling in KB and yumoto cells
por: Tabata, Sho, et al.
Publicado: (2018) -
Anti‐ganglioside GM(2) Monoclonal Antibody‐dependent Killing of Human Lung Cancer Cells by Lymphocytes and Monocytes
por: Hanibuchi, Masaki, et al.
Publicado: (1996) -
A New Quinoline Derivative MS‐209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P‐glycoprotein‐expressing Human Small Cell Lung Cancer Cells
por: Nokihara, Hiroshi, et al.
Publicado: (2001)